Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 234,007 | 407,966 | 209,910 | 46,795 | 57,553 |
| Marketable Securities | 72,176 | 20,447 | 20,352 | 9,077 | 9,052 |
| Receivables | N/A | N/A | N/A | 113 | 81 |
| TOTAL | $319,824 | $442,065 | $241,604 | $60,743 | $73,751 |
| Non-Current Assets | |||||
| PPE Net | 1,309 | 1,419 | 1,338 | 1,160 | 1,095 |
| Investments And Advances | 102,009 | 0 | 0 | 0 | 978 |
| Other Non-Current Assets | 3,115 | 12 | 0 | 2,456 | 0 |
| TOTAL | $106,433 | $1,431 | $1,338 | $3,616 | $2,073 |
| Total Assets | $426,257 | $443,496 | $242,942 | $64,359 | $75,824 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,733 | 2,354 | 2,216 | 1,911 | 1,776 |
| Accrued Expenses | 6,629 | 4,211 | 4,263 | 2,963 | 2,472 |
| TOTAL | $14,518 | $6,714 | $6,621 | $5,009 | $10,699 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 156 | 149 | 142 | 135 | 6,451 |
| TOTAL | $72 | $112 | $154 | $193 | $217 |
| Total Liabilities | $14,590 | $6,826 | $6,775 | $5,202 | $10,916 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,612 | 43,511 | 37,956 | 37,924 | 30,807 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -196,211 | -169,214 | -151,559 | -136,906 | -129,964 |
| Other shareholders' equity | 40 | -40 | -36 | -22 | -4 |
| TOTAL | $411,667 | $436,670 | $236,167 | $59,157 | $64,908 |
| Total Liabilities And Equity | $426,257 | $443,496 | $242,942 | $64,359 | $75,824 |